Gretchen Elder Brayman, MD | |
4000 Coliseum Dr Ste 320, Hampton, VA 23666-5983 | |
(757) 827-2350 | |
Not Available |
Full Name | Gretchen Elder Brayman |
---|---|
Gender | Female |
Speciality | Pulmonary Disease |
Experience | 10 Years |
Location | 4000 Coliseum Dr Ste 320, Hampton, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538587761 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 0101261582 (Virginia) | Secondary |
207RC0200X | Internal Medicine - Critical Care Medicine | 0101261582 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Sentara Careplex Hospital | Hampton, VA | Hospital |
Sentara Williamsburg Regional Medical Center | Williamsburg, VA | Hospital |
Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Sentara Medical Group | 8921903923 | 1058 |
News Archive
People with a family history of certain diseases, including heart disease and diabetes, often underestimate their risk for developing them, even after completing a risk assessment and receiving personalized prevention messages, finds a new study in the American Journal of Preventive Medicine.
Never shy of a tough question, on April 28, the Sydney University's Menzies Centre for Health Policy (MCHP) and the Oxford Health Alliance (OxHA) Asia Pacific Centre co hosted a seminar to ask Australia's three imminent major health policy reform commissions if and how they are approaching the core issue of the role of social disadvantage in health and illness.
As the Ebola Virus Diseases (EVD) epidemic continues to rage in West Africa, infectious diseases experts call attention to the striking lack of treatment guidelines. With over 16,000 total cases and more than 500 new infections reported per week, and probable underreporting of both cases and fatalities, the medical community still does not have specific approved treatment in place for Ebola, according to an editorial published in the International Journal of Infectious Diseases.
SCOLR Pharma, Inc. (Amex: DDD) today reported financial results for the three and nine months ended September 30, 2009.
In the most comprehensive review to date addressing the relative safety of hormone therapy for transgender persons, researchers from Boston University School of Medicine have found that hormone therapy in transgender adults is safe. The findings, which appear in the Journal of Clinical and Translational Endocrinology, may help reduce the barriers for transgender individuals to receive medical care.
› Verified 8 days ago
Entity Name | Sentara Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265485270 PECOS PAC ID: 8921903923 Enrollment ID: O20031203000466 |
News Archive
People with a family history of certain diseases, including heart disease and diabetes, often underestimate their risk for developing them, even after completing a risk assessment and receiving personalized prevention messages, finds a new study in the American Journal of Preventive Medicine.
Never shy of a tough question, on April 28, the Sydney University's Menzies Centre for Health Policy (MCHP) and the Oxford Health Alliance (OxHA) Asia Pacific Centre co hosted a seminar to ask Australia's three imminent major health policy reform commissions if and how they are approaching the core issue of the role of social disadvantage in health and illness.
As the Ebola Virus Diseases (EVD) epidemic continues to rage in West Africa, infectious diseases experts call attention to the striking lack of treatment guidelines. With over 16,000 total cases and more than 500 new infections reported per week, and probable underreporting of both cases and fatalities, the medical community still does not have specific approved treatment in place for Ebola, according to an editorial published in the International Journal of Infectious Diseases.
SCOLR Pharma, Inc. (Amex: DDD) today reported financial results for the three and nine months ended September 30, 2009.
In the most comprehensive review to date addressing the relative safety of hormone therapy for transgender persons, researchers from Boston University School of Medicine have found that hormone therapy in transgender adults is safe. The findings, which appear in the Journal of Clinical and Translational Endocrinology, may help reduce the barriers for transgender individuals to receive medical care.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Gretchen Elder Brayman, MD 6528 Harbour Pointe Dr, Suffolk, VA 23435-3180 Ph: (919) 796-3442 | Gretchen Elder Brayman, MD 4000 Coliseum Dr Ste 320, Hampton, VA 23666-5983 Ph: (757) 827-2350 |
News Archive
People with a family history of certain diseases, including heart disease and diabetes, often underestimate their risk for developing them, even after completing a risk assessment and receiving personalized prevention messages, finds a new study in the American Journal of Preventive Medicine.
Never shy of a tough question, on April 28, the Sydney University's Menzies Centre for Health Policy (MCHP) and the Oxford Health Alliance (OxHA) Asia Pacific Centre co hosted a seminar to ask Australia's three imminent major health policy reform commissions if and how they are approaching the core issue of the role of social disadvantage in health and illness.
As the Ebola Virus Diseases (EVD) epidemic continues to rage in West Africa, infectious diseases experts call attention to the striking lack of treatment guidelines. With over 16,000 total cases and more than 500 new infections reported per week, and probable underreporting of both cases and fatalities, the medical community still does not have specific approved treatment in place for Ebola, according to an editorial published in the International Journal of Infectious Diseases.
SCOLR Pharma, Inc. (Amex: DDD) today reported financial results for the three and nine months ended September 30, 2009.
In the most comprehensive review to date addressing the relative safety of hormone therapy for transgender persons, researchers from Boston University School of Medicine have found that hormone therapy in transgender adults is safe. The findings, which appear in the Journal of Clinical and Translational Endocrinology, may help reduce the barriers for transgender individuals to receive medical care.
› Verified 8 days ago
Dr. Sridhar Madhunapantula, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 100 Emancipation Dr, Hampton, VA 23667 Phone: 757-722-9961 | |
Hayden Allen Ross-clunis Iii, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 100 Emancipation Dr, Hampton, VA 23667 Phone: 757-722-9961 Fax: 757-728-3126 | |
Irene Paula San Roman, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 100 Emancipation Dr, Hampton, VA 23667 Phone: 757-722-9961 | |
Dr. Naga S Chigurupati, M.D. Critical Care Medicine Medicare: May Accept Medicare Assignments Practice Location: 2207 Executive Dr Ste B, Hampton, VA 23666 Phone: 757-224-8919 | |
Myung Woong Kim, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 501 Medical Dr, Hampton, VA 23666 Phone: 757-826-7785 Fax: 757-826-9028 | |
Stephen E Lapinel, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 4000 Coliseum Dr, Suite 350, Hampton, VA 23666 Phone: 757-827-2127 Fax: 757-827-2255 | |
Dr. William Edward Brown Iii, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 Manhattan Sq Ste 100, Hampton, VA 23666 Phone: 757-826-2102 Fax: 757-825-9482 |